Research Disclosures & Disclaimers

This website contains disclosures and disclaimers related to
published UBS Global Research products, including those related to
regulation, potential conflicts of interest as well as those provided
by third-party data providers describing limitations on use of their
products.

Bristol-Myers Squibb (BMY.N)*

UBS Rating and Price Target History Chart

Line chart explaining Price target vs Stock Price is described in below table

EQ Rating & Price Target Table

Date	Stock Price (US$)	Price Target (US$)	Rating
2022-11-03	78.48	75.00	Neutral
2023-01-31	72.65	77.00	Neutral
2023-04-24	70.54	76.00	Neutral
2023-04-28	66.77	75.00	Neutral
2023-07-26	63.41	70.00	Neutral
2023-10-20	56.46	60.00	Neutral
2023-10-27	51.02	57.00	Neutral
2024-01-17	49.98	52.00	Neutral
2024-04-25	44.70	47.00	Neutral
2024-07-12	40.46	43.00	Neutral
2024-07-29	48.98	50.00	Neutral
2024-10-09	52.80	54.00	Neutral
2024-11-11	59.82	60.00	Neutral
2025-04-11	50.71	54.00	Neutral
2025-04-24	48.69	52.00	Neutral
2025-07-31	43.31	46.00	Neutral
2026-01-06	54.42	65.00	Buy

Disclosures

UBS has acted as manager/co-manager in the underwriting or placement of securities of this company/entity or one of its affiliates within the past 12 months.
Within the past 12 months, UBS has received compensation for investment banking services from this company/entity or one of its affiliates.
UBS Securities LLC makes a market in the securities and/or ADRs of this company.
This company/entity is, or within the past 12 months has been, a client of UBS Securities LLC and/or its affiliates, and investment banking services are being, or have been, provided.
UBS holds a long or short position of 0.5% or more of the listed shares of this company.

Note : Historical Price Targets have been adjusted to account for any stock splits, rights issues and/or dividends which may have occurred for this security. Not Priced: Stock was not priced on the given date. No Rating: Issuer was not rated by UBS on the given day. No Price Target: For this issuer no Price Target was set by UBS on the given day. Issuers with an EQ Rating & Price Target Table are covered by UBS-IB Equity Research Analysts. Issuers without an EQ Rating & Price Target Table are not single stock covered.

* Issuers marked with an asterisk are covered by UBS-IB Equity Research Analysts. Issuers without an asterisk are not single stock covered.